/Companies

Nanitebio

Boston, US · Founded 2020 · 15 employees on LinkedIn · 2 known investors

Find your way into Nanitebio

Sign up to see every warm intro you have to Nanitebio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanitebio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.

Founders & leadership

Nanitebio was founded in 2020 by Shashi Murthy, Sean Kevlahan, and Thomas Neenan.

SMShashi Murthy
Shashi MurthyCo-Founder & Chief Technology Officer2022–2025Shashi Murthy is an executive officer at Nanitebio, which develops resorbable polymer nanoparticles for non-viral genetic drug delivery. He has previously founded and served as CTO of multiple acquired startups.
SKSean Kevlahan
Sean KevlahanChief Executive Officer and Co-Founder
TNThomas Neenan
Thomas NeenanCo-founder & CBO

Investors · 2

Reported raises · per SEC filings

Form D private placements

$4.1M disclosed across 1 round · 2022

▶$4.1MraisedMay 2022 · 11 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shashi MurthyExecutive Officer
  • Sean KevlahanExecutive Officer, Director, Promoter
  • Thomas X. NeenanExecutive Officer
Offering amount
$6.1M
Amount sold
$4.1M
First sale
May 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Companies working in the same space as Nanitebio.

Frequently asked questions

What does Nanitebio do?
Nanite develops resorbable polymer nanoparticles (PNPs) for virus-free genetic drug delivery, using high-throughput synthesis and AI to design precision delivery vectors for gene therapy. It targets subcutaneous gene therapy as an alternative to viral vectors and lipid nanoparticles.
Who founded Nanitebio?
Nanitebio was founded by Shashi Murthy, Sean Kevlahan, Thomas Neenan in 2020.
Who are Nanitebio's investors?
Nanitebio's investors include Bantam Group, Civilization Ventures Management, Llc.
How much funding has Nanitebio raised?
Nanitebio has disclosed $4.1M raised across 1 round.
Where is Nanitebio headquartered?
Nanitebio is headquartered in Boston, US.